These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8538025)

  • 1. [Malignant glioma].
    Okamura K
    Nihon Rinsho; 1995 Nov; 53(11):2678-83. PubMed ID: 8538025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenes and glial tumors.
    Watkins D; Rouleau GA
    Rev Neurol (Paris); 1992; 148(6-7):402-7. PubMed ID: 1448659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA content and chromosomal composition of malignant human gliomas.
    Bigner SH; Bjerkvig R; Laerum OD
    Neurol Clin; 1985 Nov; 3(4):769-84. PubMed ID: 3001489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W; Xu X; Yang T; Hua Z
    Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
    Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
    J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetics and molecular genetics of nervous system tumors.
    Rey JA; Pestaña A; Bello MJ
    Oncol Res; 1992; 4(8-9):321-31. PubMed ID: 1336685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular biology in cerebral gliomas: recent advances].
    Hoang-Xuan K; Li YJ; Hamelin R; Delattre O
    Rev Neurol (Paris); 1995 Nov; 151(11):608-18. PubMed ID: 8745624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
    Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
    Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
    Frankel RH; Bayona W; Koslow M; Newcomb EW
    Cancer Res; 1992 Mar; 52(6):1427-33. PubMed ID: 1347252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the TP53 gene in human gliomas.
    Rasheed BK; McLendon RE; Herndon JE; Friedman HS; Friedman AH; Bigner DD; Bigner SH
    Cancer Res; 1994 Mar; 54(5):1324-30. PubMed ID: 8118823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of brain tumors.
    Wu JK; Naber SP
    Neurosurg Clin N Am; 1994 Jan; 5(1):127-33. PubMed ID: 8124087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
    Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of molecular development of human glioma].
    Schlegel U
    Nervenarzt; 1993 Aug; 64(8):485-93. PubMed ID: 8413746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas.
    Kon H; Sonoda Y; Kumabe T; Yoshimoto T; Sekiya T; Murakami Y
    Oncogene; 1998 Jan; 16(2):257-63. PubMed ID: 9464544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
    Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P
    Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors.
    Chernova OB; Somerville RP; Cowell JK
    Oncogene; 1998 Dec; 17(22):2873-81. PubMed ID: 9879993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas.
    Xu K; Shu HK
    Cancer Res; 2007 Jul; 67(13):6121-9. PubMed ID: 17616668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific chromosomal abnormalities in malignant human gliomas.
    Bigner SH; Mark J; Burger PC; Mahaley MS; Bullard DE; Muhlbaier LH; Bigner DD
    Cancer Res; 1988 Jan; 48(2):405-11. PubMed ID: 3335011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
    Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.